Home | Add To Favorites | Sitemap


Halotestin (Fluoxymesterone)

Complete info about Halotestin (Fluoxymesterone)

Halotestin (Fluoxymesterone)
[9-alpha-fluoro-11-beta-hydroxy-17-alpha-methy1-4-androstene-3-one,17b-ol]
Formula: C20 H29 F03
Molecular Weight: 336.4457
Melting Point: 240C
Manufacturer: Upjohn, Various
Date Released: 1957
Effective Dose: 10-40mgs/day
Active life: 6-8 hours
Detection Time: 2 months
Anabolic/Androgenic ratio: 1,900/850

Halotestin is legendary among powerlifters and strength athletes. The mere word conjures up images of little mint colored pills that turn Dr. Jeckyl instantly into Mr. Hyde.

Halotestin has an absurd Anabolic and Androgenic rating. This stuff is 19 times as anabolic as testosterone and 8.5 times as androgenic! We must admit, those numbers are a bit deceiving, and can be said that Halotestin will not put anywhere near as much muscle on you as testosterone. Let's take a closer look at Halotestin, see what kind of realistic effects we can expect from it, and what kind of side-effects we'll be dealing with.

Its use in athletics and powerlifting in general is far more pronounced than its use in bodybuilding. Here, it is basically a one-trick-wonder used in the final weeks before a contest to harden up an already lean physique and gives the user some added aggression during the final calorie depleted workouts before a contest. Halotestin has no estrogenic activity, and thus will not cause any kind of water retention or most of the bad effects associated with estrogen. It is, however, hepatoxic (liver toxic) (13) and recommended keeping doses at or around 40mgs/day for a maximum of 4-6 weeks. If you are using it for its pronounced effect on aggression, you can simply use 10mgs prior to a workout. It is preferred by a lot of athletes 10mgs upon rising and 10mgs prior to a workout during the most intense weeks of a bulking or cutting cycle. This can be used with minimum HPTA inhibition.

It also has a volumizing effect on the physique, and for those who have a low a bodyfat percentage, this will immediately cause a more contest ready appearance. This is due, at least in part, to Halotestin's ability to increase mean hematocrit with hemoglobin levels as well as red cell mass (4)(5)(6). Halotestin also appears to act through cells already committed to respond to erythropoietin (11). This is good news for athletes, of course. As you can see, Halotestin has quite a profound effect on red blood cell production. This action is clearly one of the most obvious mechanisms and its effects increase strength and energy levels. It also points to the possibility of using it for athletics and sports where a high VO2 max is needed for activities such as Rugby, Mixed Martial Arts, etc...

It also exerts its effects on strength and fat loss by regulating fatty acid oxidation in the liver and fast-twitch muscle mitochondria (2). Oddly, for a drug that exerts such a nice anabolic effect and promotes such good strength gains, it has a pretty low Androgen Receptor Binding affinity (14). In this respect, it can be compared to Winstrol (Stanozolol).

As far as strength and aggression goes, Halo is a great drug. It is especially useful on a cutting or strength cycle. Its use for mass and weight gain have been pretty disappointing for most users.
Fluoxymesterone administration is (unfortunately) accompanied by a reduction in thyroid binding globulin which causes associated decreases in T3, while the free T4 index remains totally unaltered, thus, implying that thyroid function was unchanged. Remember, many anabolic steroids (notably Trenbolone) lower your T3 levels. In addition, during fluoxymesterone administration there was a reduction in testosterone, gonadotrophins and LH response to LHRH. Basal TSH did not vary, but there was a reduction in the peak and integrated TSH response to TRH. PRL levels tend to remain unchanged during fluoxymesterone use (8). Halotestin is of course suppressive to your HPTA, but can be found that in some studies where measurements were made of serum FSH, LH, testosterone, up to 20mgs per day of Halotestin did not suppress them measurably (9). This could possibly indicate the use of up to 20mgs/day of Ha lotestin without being in any great danger of suppressing endogenous hormones.

Halotestin is a testosterone derived steroid, and has an 11-beta group attached to it to inhibit aromatization. Although it is particularly prone to being 5-alpha-reduced and may cause DHT related side effects such as acne and hair loss. It is metabolized primarily by 6 beta-hydroxylation, 4-ene-reduction, 3-keto-reduction, and 11- hydroxy-oxidation. We know this by the identification of 4 particular metabolites and the tentative identification of at least 3 other metabolites. Detection of Halotestin in urine is possible for at least 5 days after a single 10 mg oral dose to previously untreated adult males. This occurs by monitoring the presence of 2 metabolites, since the parent drug is not detectable more than 1 day after the dose (12). However, the moral-compass of the athletic world, the IOC, has developed a test for fluoxymesterone metabolites that will detect them for up to 2 months after cessation of use. This item is not in high demand in bodybuilding except for as a pre-contest drug and would more likely be found circulating in Athletic and Powerlifting circles where it is more commonly used in a cycle.
Here's how your body metabolizes Fluoxymesterone:

References:

  • Treatment with anabolic steroids increases the activity of the mitochondrial outer carnitine palmitoyltransferase in rat liver and fast-twitch muscle. Biochem Pharmacol. 1991 Mar 1;41(5):833-5.
  • Effects of synthetic androgen fluoxymesterone on triglyceride secretion rates in the rat.Proc Soc Exp Biol Med. 1975 Jun;149(2):452-4.
  • Metabolism of anabolic steroids in humans: synthesis of 6 beta-hydroxy metabolites of 4-chloro-1,2-dehydro-17 alpha-methyltestosterone, fluoxymesterone, and metandienone. Steroids. 1995 Apr;60(4):353-66.
  • Influence of fluoxymesterone on in vitro erythropoiesis affected by leukemic cells.Exp Hematol. 1984 Mar;12(3):171-6.
  • [Erythropoietin in serum and urine in healthy persons and patients with chronic renal disease upon hypoxic stimulation and hypoxic stimulation after pretreatment with fluoxymesterone (author's transl)]
  • Fluoxymesterone therapy in anemia of patients on maintenance hemodialysis: comparison between patients with kidneys and anephric patients. J Dial. 1977;1(4):357-66
  • Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.Cancer. 1991 Feb 15;67(4):886-91.
  • Effect of non aromatizable androgens on LHRH and TRH responses in primary testicular failure.Horm Metab Res. 1984 Sep;16(9):492-7.
  • The effect of synthetic androgens on the hypothalamic-pituitary-gonadal axis in boys with constitutionally delayed growth. J Pediatr. 1979 Apr;94(4):657-62.
  • The effect of synthetic androgens on the hypothalamic-pituitary-gonadal axis in boys with constitutionally delayed growth. J Pediatr. 1979 Apr;94(4):657-62.
  • Steroids and hematopoiesis. II. The effect of steroids on in vitro erythroid colony growth: evidence for different target cells for different classes of steroids. J Cell Physiol. 1976 Jun;88(2):135-43.
  • Testing for fluoxymesterone (Ha lotestin) administration to man: identification of urinary metabolites by gas chromatography-mass spectrometry. J Steroid Biochem. 1990 Aug 28;36(6):659-66.
  • Toxic effects of anabolic-androgenic steroids in primary rat hepatic cell cultures. J Pharmacol Toxicol Methods. 1995 Aug;33(4):187-95.
  • Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin.Endocrinology. 1984 Jun; 114(6):2100-6.
  • The relationship of androgen to the thyrotropin and prolactin responses to thyrotropin-releasinhormonein hypogonadal and normal men. J Clin Endocrinol Metab. 1981 Feb;52(2):173-6.